{
  "Variants Include": [
    {
      "Gene": "LRRK2",
      "variants": [
        {
          "HGVS": "NM_198578.3:c.7153G>A",
          "cDNA Change": {
            "transcript": "NM_198578.3",
            "ref": "G",
            "alt": "A",
            "position": 7153
          },
          "Protein Change": {
            "ref": "G",
            "alt": "R",
            "position": 2385
          },
          "Description in input context": "Gly2385Arg heterozygote variant"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0005180"
  },
  "Experiment Method": [
    {
      "Assay Method": "MALDI-TOF mass spectrometry",
      "Material used": {
        "Material Source": "Patients Derived Material",
        "Material Name": "Genomic DNA from blood samples",
        "Description": "DNA was extracted from blood samples of study subjects."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_198578.3:c.7153G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "N.D.",
          "Result Description": "The Gly2385Arg heterozygote variant was associated with an increased risk."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "N.D."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": 0
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": 0
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": "N.D."
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "N.D."
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Multiplex genotyping assays",
      "Material used": {
        "Material Source": "Patients Derived Material",
        "Material Name": "Genomic DNA from blood samples",
        "Description": "DNA was extracted from blood samples of study subjects."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_198578.3:c.7153G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "N.D.",
          "Result Description": "The Gly2385Arg heterozygote variant was associated with an increased risk."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "N.D."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": 0
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": 0
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": "N.D."
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "N.D."
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}